Blog dermatologico

Elenco degli articoli nella categoria «Ricerca»

The 2020 International Alliance for the Control of Scabies

The 2020 International Alliance for the Control of Scabies

Ricerca

Consensus Criteria for the Diagnosis of Scabies...

Leggi tutto
Prurigo nodularis

Prurigo nodularis

Ricerca

Pathogenesis and management...

Leggi tutto
Clinical and Dermoscopic Features of Vulvar Melanosis Over the Last 20 Years

Clinical and Dermoscopic Features of Vulvar Melanosis Over the Last 20 Years

Ricerca

In this cohort study of 129 patients with vulvar melanosis and 5 to 20 years of follow-up, 67% of vulvar melanotic lesions appeared in premenopausal patients, and 65% of all patients had received some type of hormone therapy;...

Leggi tutto
Autoimmunity in Segmental Vitiligo

Autoimmunity in Segmental Vitiligo

Ricerca

The autoimmune basis of segmental vitiligo (SV) has only recently been recognized....

Leggi tutto
Selective JAK1 Inhibitors for the Treatment of Atopic Dermatitis: Focus on Upadacitinib and Abrocitinib

Selective JAK1 Inhibitors for the Treatment of Atopic Dermatitis: Focus on Upadacitinib and Abrocitinib

Ricerca

Atopic dermatitis is a common, chronic, immune-mediated disease associated with several comorbidities....

Leggi tutto
DIAGNOSTIC ACCURACY OF DERMOSCOPY OF ACTINIC KERATOSIS: A SYSTEMATIC REVIEW

DIAGNOSTIC ACCURACY OF DERMOSCOPY OF ACTINIC KERATOSIS: A SYSTEMATIC REVIEW

Ricerca

Dermoscopy is a tool that aids clinicians in the diagnosis of actinic keratosis;...

Leggi tutto
Cutaneous Melanoma Arising in Congenital Melanocytic Nevus
5‐Alpha‐Reductase Inhibitors are Associated with Reduced Frequency of COVID‐19 Symptoms in Males with Androgenetic Alopecia

5‐Alpha‐Reductase Inhibitors are Associated with Reduced Frequency of COVID‐19 Symptoms in Males with Androgenetic Alopecia

Ricerca

We have previously reported that men with androgenetic alopecia (AGA) are more likely to present with severe COVID‐19 symptoms, potentially implicating androgen sensitivity as a risk factor for COVID‐19....

Leggi tutto
Incidence of Multiple vs First Cutaneous Squamous Cell Carcinoma on a Nationwide Scale

Incidence of Multiple vs First Cutaneous Squamous Cell Carcinoma on a Nationwide Scale

Ricerca

Incidence of Multiple vs First Cutaneous Squamous Cell Carcinoma on a Nationwide Scale and Estimation of Future Incidences of Cutaneous Squamous Cell Carcinoma...

Leggi tutto
Special aspects of biologics treatment in psoriasis: management in pregnancy, lactation, surgery, renal impairment, hepatitis and tuberculosis

Special aspects of biologics treatment in psoriasis: management in pregnancy, lactation, surgery, renal impairment, hepatitis and tuberculosis

Ricerca

Biologics are modern immunomodulatory drugs, whose use in the treatment of psoriasis has led to remarkable results in psoriatic patients. The administration of these agents in special population groups, such as patients with chronic in...

Leggi tutto
Analysis of cutaneous Merkel cell carcinoma outcomes after different surgical interventions

Analysis of cutaneous Merkel cell carcinoma outcomes after different surgical interventions

Ricerca

Current guidelines recommend local excision margin (EM) with 1 to 2 cm on primary Merkel cell carcinoma (MCC) sites....

Leggi tutto
Daylight photodynamic therapy of actinic keratosis without curettage is as effective as with curettage: a randomized clinical trial

Daylight photodynamic therapy of actinic keratosis without curettage is as effective as with curettage: a randomized clinical trial

Ricerca

Guidelines for photodynamic therapy (PDT) of actinic keratosis (AK) recommend pretreatment with curettage. The impact of curettage on cure rate is, however, not well established....

Leggi tutto
Expanding treatment options for rosacea

Expanding treatment options for rosacea

Ricerca

Such a high-quality cluster randomized controlled trial involving 2040 nurses across the UK....

Leggi tutto
Immunogenicity of biologic therapies in psoriasis Myths, facts and a suggested approach

Immunogenicity of biologic therapies in psoriasis Myths, facts and a suggested approach

Ricerca

With biologic drugs dominating the therapeutic space for severe immune‐mediated inflammatory disease, it is critical for clinicians to be familiar with the concept of drug immunogenicity, with the potential for our patients to develo...

Leggi tutto
Long‐term effectiveness of dupilumab up to 52 weeks in atopic dermatitis in 253 adult patients

Long‐term effectiveness of dupilumab up to 52 weeks in atopic dermatitis in 253 adult patients

Ricerca

Dupilumab, an inhibitor of interleukin (IL)‐4/13 activity, is a biological agent approved for the treatment of moderate‐to‐severe atopic dermatitis (AD)...

Leggi tutto
Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults With Atopic Dermatitis

Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults With Atopic Dermatitis

Ricerca

Is exposure to topical calcineurin inhibitors among adult patients with atopic dermatitis associated with increased keratinocyte carcinoma risk?...

Leggi tutto
No increased risk of melanoma among patients with psoriasis treated with methotrexate

No increased risk of melanoma among patients with psoriasis treated with methotrexate

Ricerca

Patients with an impaired immune system have higher risk for melanoma, the most dangerous type of skin cancer, and a worse prognosis....

Leggi tutto

Risultati da 1 a 20 di 405